Alemtuzumab treatment for multiple sclerosis in Austria: An observational long-term outcome study.
Moser T, Foettinger F, Hitzl W, Novotna B, Berger T, Bsteh G, Di Pauli F, Hegen H, Kornek B, Langenscheidt D, Sellner J.
Moser T, et al. Among authors: hitzl w.
Ann Clin Transl Neurol. 2024 May 7. doi: 10.1002/acn3.52056. Online ahead of print.
Ann Clin Transl Neurol. 2024.
PMID: 38715245
Free article.